LQDA
Liquidia Corporation Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Liquidia (LQDA) Stock: Buy, Sell, or Hold?
$51.40
+3.53 (+7.37%)
▲
5d:
+21.8%
30d:
+85.76%
90d:
-34.76%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 10, 2026
0d
Protect LQDA Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (14%)
Quality Score
28/100
Position
EXTENDED
30-Day Fair Range
$29.94 – $45.63
Position: EXTENDED
Forward P/E & Valuation
23.5x
STRETCHED
vs 12.5x historical avg
Wall Street Target
$54.38
+5.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$41.52 / $51.69
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: LQDA is 12.6% above its trading range ($45.63). Market expects 23.4% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When LQDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.48
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$22.65
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LQDA is currently trading at $51.40, which is considered extended relative to its 30-day fair value range of $29.94 to $45.63. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.5) compared to its historical average (12.5). At these levels, the market is pricing in 23.4% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, LQDA is in a strong downtrend. The price is approaching resistance at $51.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: LQDA scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LQDA is in a strong downtrend. The price is approaching resistance at $51.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.4% recently.
Market Sentiment: LQDA scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.94 -
$45.63
Company Quality Score
28/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
14.3%
Trading Range & Key Levels
30-Day Trading Range
$29.94 -
$45.63
Current vs Trading Range
EXTENDED
Support Level
$41.52
Resistance Level
$51.69
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding LQDA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+12.6% above its trading range)
- BEARISH: Weak technical setup (3/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.4%)
- NEUTRAL: Near Wall St target ($54.38)
- BEARISH: Market expects 23.4% growth - appears too optimistic based on history
- WARNING: Composite score 28/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
23.50
Wall Street Target
$54.38
(+5.8%)
Revenue Growth (YoY)
1842.7%
Profit Margin
30.7%
Valuation Premium vs History
+23.4% premium
PE vs Historical
23.5 vs 12.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+23.4%
(market-implied from PE analysis)
1-Year Target
$63.43
(+23%)
2-Year Target
$78.27
(+52%)
3-Year Target
$96.58
(+88%)
3-Yr Target (if PE normalizes)
(PE: 24→13)
PE COMPRESSION
$51.37
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 7.9%)
$64.56
(+26%)
Base:
(SPY PE: 19.9, Growth: 7.9%)
$54.55
(+6%)
Bear:
(PE: 12.5, Growth: 7.9%)
$34.34
(-33%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 34.44 | Current EPS (TTM): $1.39
Bull Case
$82.85
(+61%)
Analyst growth 57.3%, PE expands to 37.9
Base Case
$75.32
(+47%)
Market implied 57.3%, PE stable at 34.4
Bear Case
$32.55
(-37%)
Severe decline -20.0%, PE contracts to 29.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share LQDA Analysis
Share this live LQDA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LQDA)
Bearish
4 Retail Mentions
Reddit / WSB Comments
3
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Liquidia Corporation (LQDA) reported a 31% sequential increase in net product sales and finalized a global settlement to resolve multiyear litigation with United Therapeutics. Record October patient shipments were achieved with a conversion rate above 87% and a widening prescriber base.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:52 AM ET
Data refreshes hourly during market hours. Next update: 9:52 AM
Data refreshes hourly during market hours. Next update: 9:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LQDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 28 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 38 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 41 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 45 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 51 HOLD |
Advanced LQDA Option Strategies
Professional options setups generated by AI based on today's LQDA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LQDA Research Pages